VISX US Lasik patent held to be valid
This article was originally published in Clinica
Executive Summary
The US Patent Office has supported Visx' three year battle to protect one of its key US patents for Lasik surgery, by upholding and even extending the claims in the face of a challenge that prior art had invalidated the protection.